Larvol Delta - aTyr-Pharma-Provides-Regulatory-and-Clinical-Update-for-Efzofitimod-in-Pulmonary-Sarcoidosis-Following-FDA-Type-C-Meeting

Stalaris (efzofitimod) - aTyr Pharma, Kyorin

https://finance.yahoo.com/sectors/healthcare/articles/atyr-pharma-provides-regulatory-clinical-200100895.html

May 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next